Loading clinical trials...
Loading clinical trials...
This phase I study will determine the pharmacokinetic profile of patupilone in patients with mild or moderately impaired hepatic function within 2 cycles of treatment. The study population for this tr...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Novartis Pharmaceuticals
NCT07539441 · Central Nervous System Tumors, Glioma
NCT04570423 · Solid Tumors, Lymphoma
NCT07489378 · Very Rare Tumors, Very Rare Cancers, and more
NCT03206060 · Pheochromocytoma, Paraganglioma, and more
NCT06926283 · Prostate Cancer, Other Solid Tumors, and more
University of California San Diego/Moores Cancer Center
La Jolla, California
Cancer Research and Treatment Center
Albuquerque, New Mexico
Institute for Drug Development Cancer Therapy & Research Center/The University of Texas Health Science
San Antonio, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions